British Heart Foundation Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow G12 8TA, UK.
Nat Rev Cardiol. 2012 Jan 25;9(2):73-4. doi: 10.1038/nrcardio.2011.212.
Studies published in 2011 in the field of heart failure have reinforced the benefit of cardiac resynchronization therapy in patients with mild symptoms and confirmed the value of left ventricular assist devices and CABG surgery in selected patients. Conversely, the efficacy of nesiritide in acute heart failure has been questioned.
2011 年发表于心力衰竭领域的研究结果进一步证实了心脏再同步治疗对有轻度症状的患者有益，同时也确认了左心室辅助装置和冠状动脉旁路移植术在特定患者中的价值。相反，奈西立肽治疗急性心力衰竭的疗效受到了质疑。
